Annual Reports in Medicinal Chemistry, Volume 37

1st Edition

Editors: Annette Doherty
Hardcover ISBN: 9780120405374
eBook ISBN: 9780080916224
Imprint: Academic Press
Published Date: 2nd October 2002
Page Count: 364

Institutional Access

Table of Contents

I. CENTRAL NERVOUS SYSTEM DISEASES Section Editor: David W. Robertson, Pfizer Global Research & Development, Ann Arbor, MI 1. Promise and Progress of Central G-Protein Coupled Receptor Modulators 1 for Obesity Treatments Brian L. Largent, Albert J. Robichaud and Keith J. Miller, Bristol-Myers Squibb Company, Wilmington, Delaware 2. Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of 11 New Treatments Shelly A. Glase, Larry D. Wise and David W. Robertson, Pfizer Global Research and Development, Ann Arbor, Michigan 3. 5-HT2C Receptor Modulators: Progress in Development of 21 New CNS Medicines Larry E. Fitzgerald and Michael D. Ennis, Pharmacia Corporation, Kalamazoo, Michigan 4. Emerging Themes in Alzheimer's Disease Research: Paradigm Shift in Drug Discovery 31 Todd Morgan, School of Gerontology, University of Southern California, Los Angeles, California and Grant A. Krafft, Acumen Pharmaceuticals, Glenview, Illinois II. CARDIOVASCULAR AND PULMONARY DISEASES Section Editor: William J. Greenlee, Schering-Plough Research Institute, Kenilworth, New Jersey 5. Recent Advances in Pulmonary Hypertension Therapy 41 Russell A. Bialecki, AstraZeneca Pharmaceuticals, Wilmington, Delaware 6. Phosphodiesterase 5 Inhibitors 53 Andrew W. Stamford, Schering-Plough Research Institute, Kenilworth, New Jersey 7. Antagonists of VLA-4 65 George W. Holland, Ronald J. Biediger,


Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.


Medicinal, pharmaceutical, and organic chemists.


No. of pages:
© Academic Press 2003
Academic Press
eBook ISBN:
Hardcover ISBN:


"This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development." —ENZYMOLOGIA "This book is strongly recommended for researchers, teachers, students, administrators—in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inclusion in the scientist's personal library." —JOURNAL OF MEDICINAL CHEMISTRY "All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry." —JOURNAL OF PHARMACEUTICAL SCIENCES

About the Editors

Annette Doherty Editor

Affiliations and Expertise

Pfizer Global R&D, Sandwich Laboratories, United Kingdom